Skip to content
Catalyst

PapersPMID:25629804

Chondroitin for osteoarthritis.

The Cochrane database of systematic reviews2015The record ↗

  1. Finding, very limited evidencelowersSerious adverse event incidence

What moved

1 findingHow to read these marks →
  • “Chondroitin was associated with statistically significantly lower odds of serious adverse events compared with placebo with Peto odds ratio of 0.40 (95% CI 0.19 to 0.82; n = 6 trials) (level of evidence, moderate).”
    Study
    meta-analysis
    Effect
    0.4 odds ratio, 95% CI 0.19 to 0.82
    Population
    adults with osteoarthritis (knee, hip or hand); pooled across 6 trials

Study record

Design
meta-analysis
Species
human
Population
adults with osteoarthritis (knee, hip, or hand), pooled from 43 RCTs
Participants
9,110
Comparator
placebo
Duration
not reported
Endpoints measured
9